Europe is currently a world leader in the fundamental science underpinning regenerative medicine and cell therapy, and in its therapeutic use and regulation. But how can Europe build on its leading position?
Get your free copy
Free
Europe is currently a world leader in the fundamental science underpinning regenerative medicine and cell therapy, and in its therapeutic use and regulation. But for the full advantages of cell therapy to be delivered, there must be evidence from properly regulated clinical trials of long-term benefits, allowing this new form of medicine to move from the hospital-scale, autologous model on which it operates today to a scaled-up, regulated European – and global – industry.
/system/files/reports/Experts_debate_the_future_of_stem_cells.pdf
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
